Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee Ratner

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Virology|July 13, 2019
The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65<sup>RelA</sup>-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instabilityAditi Malu, Tetiana Hutchison, Laçin Yapindi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic AcidMaryjo Lechowicz, Dirk P Dittmer, Jeannette Y Lee, et al.
Plos Pathogens|March 23, 2018
PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized miceEléonore Pérès, Juliana Blin, Emiliano P Ricci, et al.
Virology|May 20, 2018
The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30<sup>II</sup> and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphomaTetiana Hutchison, Aditi Malu, Laçin Yapindi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium TrialJoseph A Sparano, Jeannette Y Lee, Joel Palefsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium studyMary Cianfrocca, Timothy P Cooley, Jeannette Y Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.
Virology|February 21, 2018
The human T-cell leukemia virus type-1 p30<sup>II</sup> protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesisMegan Romeo, Tetiana Hutchison, Aditi Malu, et al.
Journal of Virology|January 9, 2024
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbitsJoshua J Tu, Emily King, Victoria Maksimova, et al.
Cancer Reports (Hoboken, N.J.)|June 1, 2026
Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus-Associated DisordersKandice Roberts, Paula Valiño Ramos, Saurabh Jindal, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Virology|July 13, 2019
The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-κB p65<sup>RelA</sup>-Stathmin complexes and causes catastrophic mitotic spindle damage and genomic instabilityAditi Malu, Tetiana Hutchison, Laçin Yapindi, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 17, 2009
Molecular and clinical assessment in the treatment of AIDS Kaposi sarcoma with valproic AcidMaryjo Lechowicz, Dirk P Dittmer, Jeannette Y Lee, et al.
Plos Pathogens|March 23, 2018
PDZ domain-binding motif of Tax sustains T-cell proliferation in HTLV-1-infected humanized miceEléonore Pérès, Juliana Blin, Emiliano P Ricci, et al.
Virology|May 20, 2018
The TP53-Induced Glycolysis and Apoptosis Regulator mediates cooperation between HTLV-1 p30<sup>II</sup> and the retroviral oncoproteins Tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphomaTetiana Hutchison, Aditi Malu, Laçin Yapindi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2016
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium TrialJoseph A Sparano, Jeannette Y Lee, Joel Palefsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium studyMary Cianfrocca, Timothy P Cooley, Jeannette Y Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2023
Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087)Missak Haigentz, Jeannette Y Lee, Elizabeth Y Chiao, et al.
Virology|February 21, 2018
The human T-cell leukemia virus type-1 p30<sup>II</sup> protein activates p53 and induces the TIGAR and suppresses oncogene-induced oxidative stress during viral carcinogenesisMegan Romeo, Tetiana Hutchison, Aditi Malu, et al.
Journal of Virology|January 9, 2024
An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbitsJoshua J Tu, Emily King, Victoria Maksimova, et al.
Cancer Reports (Hoboken, N.J.)|June 1, 2026
Case Report: Synchronous Manifestations of Kaposi Sarcoma Herpesvirus-Associated DisordersKandice Roberts, Paula Valiño Ramos, Saurabh Jindal, et al.
Pageof 15